Smith & Nephew plc (SNN)
USD 26.8
(0.6%)
USD 26.8
(0.6%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 4.77 Billion USD | 1.34% |
| 2022 | 4.7 Billion USD | -12.05% |
| 2021 | 5.35 Billion USD | -6.65% |
| 2020 | 5.73 Billion USD | 37.88% |
| 2019 | 4.15 Billion USD | 30.55% |
| 2018 | 3.18 Billion USD | -1.15% |
| 2017 | 3.22 Billion USD | -4.84% |
| 2016 | 3.38 Billion USD | 5.78% |
| 2015 | 3.2 Billion USD | -1.99% |
| 2014 | 3.26 Billion USD | 84.31% |
| 2013 | 1.77 Billion USD | 0.8% |
| 2012 | 1.75 Billion USD | 12.69% |
| 2011 | 1.56 Billion USD | -20.41% |
| 2010 | 1.96 Billion USD | -17.85% |
| 2009 | 2.38 Billion USD | -15.06% |
| 2008 | 2.8 Billion USD | 6.2% |
| 2007 | 2.64 Billion USD | 150.24% |
| 2006 | 1.05 Billion USD | -31.41% |
| 2005 | 1.54 Billion USD | -2.03% |
| 2004 | 1.57 Billion USD | 45.87% |
| 2003 | 1.07 Billion USD | -7.02% |
| 2002 | 1.15 Billion USD | 14.89% |
| 2001 | 1 Billion USD | -2.7% |
| 2000 | 1.03 Billion USD | 49.65% |
| 1999 | 693.34 Million USD | -0.5% |
| 1998 | 696.82 Million USD | 4.86% |
| 1997 | 664.55 Million USD | -4.51% |
| 1996 | 695.96 Million USD | 7.55% |
| 1995 | 647.13 Million USD | 3.59% |
| 1994 | 624.73 Million USD | -21.19% |
| 1993 | 792.7 Million USD | -0.31% |
| 1992 | 795.2 Million USD | -23.83% |
| 1991 | 1.04 Billion USD | 3.09% |
| 1990 | 1.01 Billion USD | 6.46% |
| 1989 | 951.21 Million USD | 13.33% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 5.33 Billion USD | 0.0% |
| 2023 Q2 | 4.61 Billion USD | 0.0% |
| 2023 FY | 4.77 Billion USD | 1.34% |
| 2023 Q4 | 4.77 Billion USD | 0.0% |
| 2022 Q4 | 4.7 Billion USD | 0.0% |
| 2022 Q2 | 4.71 Billion USD | 0.0% |
| 2022 FY | 4.7 Billion USD | -12.05% |
| 2021 FY | 5.35 Billion USD | -6.65% |
| 2021 Q2 | 5.6 Billion USD | 0.0% |
| 2021 Q4 | 5.35 Billion USD | 0.0% |
| 2020 Q2 | 4.57 Billion USD | 0.0% |
| 2020 Q4 | 5.73 Billion USD | 0.0% |
| 2020 FY | 5.73 Billion USD | 37.88% |
| 2019 FY | 4.15 Billion USD | 30.55% |
| 2019 Q4 | 4.15 Billion USD | 0.0% |
| 2019 Q2 | 3.99 Billion USD | 0.0% |
| 2018 Q4 | 3.18 Billion USD | 0.0% |
| 2018 Q2 | 3.07 Billion USD | 0.0% |
| 2018 FY | 3.18 Billion USD | -1.15% |
| 2017 FY | 3.22 Billion USD | -4.84% |
| 2017 Q4 | 3.22 Billion USD | 0.0% |
| 2017 Q2 | 3.23 Billion USD | 0.0% |
| 2016 Q4 | 3.38 Billion USD | 0.0% |
| 2016 FY | 3.38 Billion USD | 5.78% |
| 2016 Q2 | 3.55 Billion USD | 0.0% |
| 2015 FY | 3.2 Billion USD | -1.99% |
| 2015 Q2 | 3.16 Billion USD | 0.0% |
| 2015 Q4 | 3.2 Billion USD | 0.0% |
| 2014 Q4 | 3.26 Billion USD | 0.0% |
| 2014 FY | 3.26 Billion USD | 84.31% |
| 2014 Q2 | 3.58 Billion USD | 0.0% |
| 2013 Q4 | 1.77 Billion USD | 0.0% |
| 2013 Q2 | 1.55 Billion USD | 0.0% |
| 2013 FY | 1.77 Billion USD | 0.8% |
| 2012 Q4 | 1.75 Billion USD | 29.74% |
| 2012 Q1 | 1.43 Billion USD | -8.27% |
| 2012 FY | 1.75 Billion USD | 12.69% |
| 2012 Q2 | 1.25 Billion USD | -12.3% |
| 2012 Q3 | 1.35 Billion USD | 7.97% |
| 2011 FY | 1.56 Billion USD | -20.41% |
| 2011 Q4 | 1.56 Billion USD | -11.56% |
| 2011 Q3 | 1.76 Billion USD | -0.68% |
| 2011 Q2 | 1.77 Billion USD | -0.62% |
| 2011 Q1 | 1.78 Billion USD | -8.83% |
| 2010 Q1 | 2.3 Billion USD | -3.23% |
| 2010 Q2 | 2.27 Billion USD | -1.56% |
| 2010 FY | 1.96 Billion USD | -17.85% |
| 2010 Q3 | 2.4 Billion USD | 5.59% |
| 2010 Q4 | 1.96 Billion USD | -18.33% |
| 2009 FY | 2.38 Billion USD | -15.06% |
| 2009 Q4 | 2.38 Billion USD | -8.86% |
| 2009 Q2 | 2.63 Billion USD | 1.54% |
| 2009 Q3 | 2.61 Billion USD | -0.76% |
| 2009 Q1 | 2.59 Billion USD | -7.51% |
| 2008 Q3 | 2.75 Billion USD | -5.13% |
| 2008 FY | 2.8 Billion USD | 6.2% |
| 2008 Q1 | 2.87 Billion USD | 9.3% |
| 2008 Q2 | 2.9 Billion USD | 0.8% |
| 2008 Q4 | 2.8 Billion USD | 2.03% |
| 2007 Q1 | 1.06 Billion USD | 0.28% |
| 2007 Q2 | 2.14 Billion USD | 102.17% |
| 2007 Q4 | 2.63 Billion USD | 11.56% |
| 2007 Q3 | 2.36 Billion USD | 10.17% |
| 2007 FY | 2.64 Billion USD | 150.24% |
| 2006 Q4 | 1.05 Billion USD | -7.36% |
| 2006 FY | 1.05 Billion USD | -31.41% |
| 2006 Q1 | 1.22 Billion USD | 37.37% |
| 2006 Q2 | 1.16 Billion USD | -5.15% |
| 2006 Q3 | 1.14 Billion USD | -1.72% |
| 2005 Q4 | 891 Million USD | -42.48% |
| 2005 Q3 | 1.54 Billion USD | -2.45% |
| 2005 Q2 | 1.58 Billion USD | -0.88% |
| 2005 Q1 | 1.6 Billion USD | 20.59% |
| 2005 FY | 1.54 Billion USD | -2.03% |
| 2004 Q1 | 1.2 Billion USD | -2.68% |
| 2004 FY | 1.57 Billion USD | 45.87% |
| 2004 Q4 | 1.32 Billion USD | 7.54% |
| 2004 Q3 | 1.23 Billion USD | 3.47% |
| 2004 Q2 | 1.19 Billion USD | -0.72% |
| 2003 Q2 | 1.21 Billion USD | 2.12% |
| 2003 Q1 | 1.18 Billion USD | 2.48% |
| 2003 Q3 | 1.09 Billion USD | -10.23% |
| 2003 FY | 1.07 Billion USD | -7.02% |
| 2003 Q4 | 1.23 Billion USD | 13.35% |
| 2002 Q2 | 1.17 Billion USD | 0.0% |
| 2002 Q4 | 1.16 Billion USD | 0.0% |
| 2002 FY | 1.15 Billion USD | 14.89% |
| 2001 FY | 1 Billion USD | -2.7% |
| 2001 Q2 | 1.01 Billion USD | 0.0% |
| 2001 Q4 | 1 Billion USD | 0.0% |
| 2000 Q2 | 1.61 Billion USD | 0.0% |
| 2000 Q4 | 1.03 Billion USD | 0.0% |
| 2000 FY | 1.03 Billion USD | 49.65% |
| 1999 Q2 | 561 Million USD | 0.0% |
| 1999 Q4 | 693.34 Million USD | 0.0% |
| 1999 FY | 693.34 Million USD | -0.5% |
| 1998 FY | 696.82 Million USD | 4.86% |
| 1997 FY | 664.55 Million USD | -4.51% |
| 1996 FY | 695.96 Million USD | 7.55% |
| 1995 FY | 647.13 Million USD | 3.59% |
| 1994 FY | 624.73 Million USD | -21.19% |
| 1993 FY | 792.7 Million USD | -0.31% |
| 1992 FY | 795.2 Million USD | -23.83% |
| 1991 FY | 1.04 Billion USD | 3.09% |
| 1990 FY | 1.01 Billion USD | 6.46% |
| 1989 FY | 951.21 Million USD | 13.33% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Abbott Laboratories | 34.38 Billion USD | 86.128% |
| Allurion Technologies Inc. | 142.19 Million USD | -3254.454% |
| Artivion, Inc. | 510.61 Million USD | -834.164% |
| Avanos Medical, Inc. | 456.1 Million USD | -945.823% |
| Butterfly Network, Inc. | 84.22 Million USD | -5563.671% |
| Butterfly Network, Inc. | 84.22 Million USD | -5563.671% |
| Bio-Rad Laboratories, Inc. | 3.55 Billion USD | -34.066% |
| Boston Scientific Corporation | 15.6 Billion USD | 69.435% |
| CONMED Corporation | 1.46 Billion USD | -225.42% |
| Edwards Lifesciences Corporation | 2.64 Billion USD | -80.422% |
| Paragon 28, Inc. | 162.95 Million USD | -2827.135% |
| Glaukos Corporation | 478.64 Million USD | -896.557% |
| Globus Medical, Inc. | 1.08 Billion USD | -338.369% |
| Inspire Medical Systems, Inc. | 104.29 Million USD | -4473.478% |
| Integer Holdings Corporation | 1.41 Billion USD | -237.526% |
| Medtronic plc | 39.56 Billion USD | 87.943% |
| Myomo, Inc. | 5.59 Million USD | -85197.104% |
| Nevro Corp. | 330.31 Million USD | -1344.094% |
| Owlet, Inc. | 73.79 Million USD | -6363.502% |
| Penumbra, Inc. | 377.36 Million USD | -1164.042% |
| Vicarious Surgical Inc. | 21.89 Million USD | -21685.796% |
| Sonendo, Inc. | 49.74 Million USD | -9489.675% |
| STERIS plc | 4.74 Billion USD | -0.456% |
| Stryker Corporation | 21.31 Billion USD | 77.626% |
| Vapotherm, Inc. | 132.95 Million USD | -3487.788% |
| Zimmer Biomet Holdings, Inc. | 9 Billion USD | 47.051% |